Skip to main content
Clinical Trials/NCT04734561
NCT04734561
Completed
Not Applicable

Effects of Respiratory Muscle Training on Quality of Life, Physical and Pulmonary Function and Psychological Status in Patients Who Have Had COVID-19 Disease

Universidad Complutense de Madrid1 site in 1 country88 target enrollmentFebruary 8, 2021

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Covid19
Sponsor
Universidad Complutense de Madrid
Enrollment
88
Locations
1
Primary Endpoint
Exercise tolerance
Status
Completed
Last Updated
4 years ago

Overview

Brief Summary

The main objective of the present study is to observe the short-term effects of respiratory muscle training applied by telerehabilitation on quality of life and exercise tolerance in people who have had the COVID-19 disease. As secondary objectives, the effects on respiratory muscles strength/tolerance, pulmonary function and psychological and cognitive factors.

Detailed Description

It is a double-blind randomized clinical trial study. Each participant will be randomly assigned to one of the following groups: 1) Inspiratory muscle training, 2) Placebo Inspiratory muscle training, 3) Inspiratory muscle training + Expiratory muscle training, 4) Placebo Inspiratory muscle training + Expiratory muscle training. Each exercise training program will be applied twice per day 7 sessions per week during 8 weeks by a threshold device. The evening sessions will be supervised by a physiotherapist through a virtual platform. Participants received baseline assessments at the beginning of the intervention, at the end of the 4th week, and post-intervention assessments at the end of the 8th week.

Registry
clinicaltrials.gov
Start Date
February 8, 2021
End Date
September 29, 2021
Last Updated
4 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ibai López de Uralde Villanueva

Professor Ibai López de Uralde Villanueva

Universidad Complutense de Madrid

Eligibility Criteria

Inclusion Criteria

  • Positive diagnosis of COVID-19 (SARS-CoV2)
  • Hospital admission for COVID-19 in the last 3 months
  • Stable phase and home discharge;

Exclusion Criteria

  • Severe cognitive impairment
  • Any type of musculoskeletal, neurological, cardiac or respiratory disease where training is contraindicated
  • Inability to carry out the training program through telematic supervision.

Outcomes

Primary Outcomes

Exercise tolerance

Time Frame: Change from Baseline Exercise tolerance at 8 weeks

Exercise tolerance will be evaluated by a test consisted on 30 squats based on three different heart rate measuring moments (resting heart rate, heart rate after exercise, heart rate after longer period) evaluating the speed at which the heart rate increases/decreases.

Health-related quality of life

Time Frame: Change from Baseline Health-related quality of life at 8 weeks

To evaluate the health-related quality of life of the participants a valid, reliable and generic questionnaire will be used. It consisted of five dimensions (Mobility, Self-care, Usual activities, Pain \& discomfort, Anxiety \& depression), each of which has five severity levels that are described by statements appropriate to that dimension.

Secondary Outcomes

  • Inspiratory muscle endurance(Change from Baseline Inspiratory muscle endurance at 8 weeks)
  • Upper limb muscle strength(Change from Baseline Peripheral muscle strength at 8 weeks)
  • Maximum respiratory pressures(Change from Baseline Maximum respiratory pressures at 8 weeks)
  • Cognitive factors(Change from Baseline cognitive factors at 8 weeks)
  • Psychological factors(Change from Baseline Psychological factors at 8 weeks)
  • Lung function (forced spirometry)(Change from Baseline Lung function at 8 weeks)
  • Lower limb muscle strength(Change from Baseline Lower limb strength at 8 weeks)

Study Sites (1)

Loading locations...

Similar Trials